Published in Clin Exp Immunol on November 01, 1992
The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med (2010) 1.83
Expression of alpha and beta subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads. Ann Rheum Dis (1998) 0.88
Effects of agarose mould compliance and surface roughness on self-assembled meniscus-shaped constructs. J Tissue Eng Regen Med (2009) 0.87
Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells. Tissue Eng Part A (2011) 0.87
Chondrocyte phenotyping in human osteoarthritis. Clin Rheumatol (1998) 0.85
Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells. Rheumatol Int (2006) 0.80
Chondrocyte-peripheral blood mononuclear cell interactions: the role of ICAM-1. Immunology (1995) 0.76
Cytotoxic T lymphocytes recognize and lyse chondrocytes under inflammatory, but not non-inflammatory conditions. Immunology (2003) 0.75
Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells. Front Immunol (2016) 0.75
Adhesion receptors of the immune system. Nature (1990) 28.86
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 5.64
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A (1986) 5.60
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med (1977) 4.59
The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum (1977) 3.49
The leukocyte integrins. Adv Immunol (1989) 3.24
The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol (1988) 3.05
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med (1987) 2.69
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature (1989) 2.61
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell (1988) 2.36
Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol (1985) 2.27
Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum (1987) 2.04
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest (1988) 1.89
IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol (1990) 1.86
The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol (1990) 1.83
IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol (1990) 1.82
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum (1988) 1.54
Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol (1990) 1.53
Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol (1988) 1.46
Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. J Clin Invest (1976) 1.43
Two subpopulations of differentiated chondrocytes identified with a monoclonal antibody to keratan sulfate. J Cell Biol (1985) 1.41
S-100 protein in human chondrocytes. Nature (1982) 1.35
Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med (1979) 1.32
Intracellular collagen fibers at the pannus-cartilage junction in rheumatoid arthritis. Arthritis Rheum (1977) 1.30
Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol (1990) 1.25
Immunopathologic role of proteoglycan antigens in rheumatoid joint disease. Scand J Immunol (1980) 1.16
Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes. J Immunol (1985) 1.14
Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochem Biophys Res Commun (1986) 1.13
Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1986) 1.12
Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases. Arthritis Rheum (1990) 1.09
Transforming growth factor beta: an autocrine regulator of chondrocytes. Connect Tissue Res (1989) 1.08
Changes in cell surface antigen expression on human articular chondrocytes induced by gamma-interferon. Induction of Ia antigens. Arthritis Rheum (1987) 1.06
Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum (1981) 1.05
The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. Arthritis Rheum (1990) 1.05
Tissue-specific expression of allogeneic class II MHC molecules induces neither tissue rejection nor clonal inactivation of alloreactive T cells. J Immunol (1990) 1.02
Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum (1989) 1.01
Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01
Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells. Eur J Immunol (1989) 1.00
Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J Immunol (1990) 0.99
Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation. Clin Immunol Immunopathol (1987) 0.99
Application of monoclonal antibodies to the characterization of cells eluted from human articular cartilage. Expression of Ia antigens in certain diseases and identification of an 85-kD cell surface molecule accumulated in the pericellular matrix. Arthritis Rheum (1983) 0.98
Chondrocyte-derived cells and matrix at the rheumatoid cartilage-pannus junction identified with monoclonal antibodies. Rheumatol Int (1987) 0.96
Antigenicity and accessory cell function of human articular chondrocytes. J Rheumatol (1991) 0.87
Surface ultrastructure of rheumatoid articular cartilage. Arthritis Rheum (1977) 0.86
The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol Suppl (1989) 0.86
Activation of rabbit articular chondrocytes by recombinant human cytokines. J Rheumatol (1987) 0.86
A role for cytokines in antigen presentation: IL-1 and IL-4 induce accessory functions of antigen-presenting cells. J Immunol (1990) 0.84
The mechanism of cartilage destruction in rheumatoid arthritis. Arthritis Rheum (1985) 0.80
Immuno-electron microscopy of chondrocyte-derived cells in the rheumatoid cartilage-pannus junction. Rheumatol Int (1988) 0.79
The site dependence of the articular cartilage transplant reaction. J Bone Joint Surg Br (1978) 0.76
The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol (1991) 0.76
Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet (1981) 6.62
BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology (Oxford) (2006) 3.22
The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol (1988) 3.05
Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol (1982) 2.86
Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum (1992) 2.31
Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol (1980) 2.16
A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism. Lancet (1978) 2.15
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol (1992) 1.83
HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol (1984) 1.79
Targeted therapies in rheumatoid arthritis: the need for action. Rheumatology (Oxford) (1999) 1.78
Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. Clin Exp Immunol (1982) 1.75
The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc Natl Acad Sci U S A (1991) 1.67
The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis. Clin Exp Immunol (1983) 1.56
Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis (1996) 1.47
Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol (1987) 1.47
Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol (2004) 1.43
Adalimumab-induced asthma. Rheumatology (Oxford) (2005) 1.38
Management of septic arthritis: a systematic review. Ann Rheum Dis (2007) 1.37
Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid. Ann Rheum Dis (1974) 1.21
Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter's disease. Arthritis Rheum (1991) 1.19
Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis (1984) 1.16
Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation. J Rheumatol (1987) 1.11
Lymphocyte studies in rheumatoid arthritis. III. A comparative study of the responses of peripheral blood and synovial fluid lymphocytes to phytomitogens. Scand J Rheumatol (1979) 1.07
Detection of immune complexes in serum of patients with ankylosing spondylitis. Ann Rheum Dis (1978) 1.05
Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol (1992) 1.05
T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis. Clin Exp Immunol (1993) 1.03
Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure. Rheumatology (Oxford) (2005) 1.01
Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol (1997) 1.00
Functional assay of cytotoxic lymphocytes involved in antibody-mediated cytotoxicity in normal and rheumatoid subjects. Ann Rheum Dis (1977) 0.97
Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.96
Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol (1995) 0.93
Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) (2000) 0.92
Recent advances in the pathogenesis of reactive arthritis. Immunol Today (1996) 0.92
Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1992) 0.89
Monocyte activation in rheumatoid arthritis: evidence for in situ activation and differentiation in joints. Br J Rheumatol (1990) 0.88
Expression and function of CD5 and CD28 in patients with rheumatoid arthritis. Immunology (1993) 0.87
Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scand J Immunol (1992) 0.87
T-lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br J Rheumatol (1996) 0.86
Immunotherapy of rheumatic diseases--practice and prospects. Immunol Today (1991) 0.84
Antigenic responses in reactive arthritis. Rheum Dis Clin North Am (1992) 0.84
Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br J Rheumatol (1993) 0.84
Management of septic arthritis: a systematic review. Postgrad Med J (2008) 0.84
T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J Clin Immunol (1982) 0.82
The glucocorticoid inhibition of LFA-1 and CD2 expression by human mononuclear cells is reversed by IL-2, IL-7 and IL-15. Eur J Immunol (2001) 0.81
Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum (1997) 0.81
Systemic sclerosis occurring in a patient with Adamantiades-Behçet's disease. Br J Rheumatol (1993) 0.81
Large granular lymphocyte expansions in Felty's syndrome have an unusual phenotype of activated CD45RA+ cells. Br J Rheumatol (1996) 0.80
Activation of HLA-DR and interleukin-6 gene transcription in resting T cells via the CD2 molecule: relevance to chronic immune-mediated inflammation. Scand J Immunol (1992) 0.80
Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy. Ann Rheum Dis (1994) 0.80
The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens. Agents Actions (1979) 0.79
Immunoregulation in the rheumatic diseases. Scand J Rheumatol Suppl (1980) 0.79
Immunotherapy in rheumatic disease: an idea whose time has come--or gone? Immunol Today (1996) 0.78
Mechanisms of action of second-line agents and choice of drugs in combination therapy. Clin Exp Rheumatol (2000) 0.78
Alteration in T cell/macrophage ratio may reveal lymphocyte proliferation specific for the triggering antigen in reactive arthritis. Scand J Immunol (1992) 0.78
They turned down my abstract again... Br J Rheumatol (1995) 0.78
Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J Rheumatol (1995) 0.78
Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7. Clin Exp Immunol (1991) 0.77
Enumeration of interleukin-1 alpha and beta producing cells by flow cytometry. J Immunol Methods (1992) 0.77
Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study. Scand J Rheumatol (1994) 0.77
Discovertebral destruction in ankylosing spondylitis complicated by spinal cord compression. Ann Rheum Dis (1988) 0.77
Differences in the management of shoulder pain between primary and secondary care in Europe: time for a consensus. Ann Rheum Dis (2004) 0.77
The control of cyclic GMP by calcium, ionophore A23187, potassium and acetycholine in enzyme-secreting pancreatic slices [proceedings]. J Physiol (1977) 0.77
The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol (1991) 0.76
Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination. Baillieres Clin Rheumatol (1992) 0.76
Hematologic and cytofluorographic analysis of patients with Felty's syndrome. A hypothesis that a discrete event leads to large granular lymphocyte expansions in this condition. Arthritis Rheum (1995) 0.76
Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response? Ann Rheum Dis (1994) 0.75
Penicillamine nephropathy. Br Med J (Clin Res Ed) (1988) 0.75
[Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane]. Reumatismo (2002) 0.75
Expression of the 65 kD heat shock protein in human chondrocytes. Br J Rheumatol (1993) 0.75
Lymphocyte studies in rheumatoid arthritis. IV. Evidence for a prostaglandin-producing suppressor cell. Agents Actions Suppl (1979) 0.75
Monoclonal antibody therapy in rheumatic disease. Presse Med (1994) 0.75
Comment on the articles by Firestein and Zvaifler. Arthritis Rheum (1988) 0.75
How do second-line agents work? Br Med Bull (1995) 0.75
A complicated case of systemic lupus erythematosus. Br J Rheumatol (1993) 0.75
A comparison of conflict tactics in the supervisory process. J Speech Hear Res (1996) 0.75
Differential dosing study of pirazolac, a new non-steroidal anti-inflammatory agent, in patients with rheumatoid arthritis. Curr Med Res Opin (1985) 0.75
Reiter's syndrome--a possible consequence of artificial insemination? Br J Rheumatol (1985) 0.75